Privia Health Return on Tangible Equity 2020-2024 | PRVA

Current and historical return on tangible equity values for Privia Health (PRVA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Privia Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.01B $0.42B 3.34%
2024-06-30 $0.02B $0.40B 4.04%
2024-03-31 $0.02B $0.38B 5.33%
2023-12-31 $0.02B $0.36B 6.70%
2023-09-30 $0.04B $0.35B 11.28%
2023-06-30 $0.03B $0.34B 10.42%
2023-03-31 $0.02B $0.32B 5.46%
2022-12-31 $-0.01B $0.34B -2.68%
2022-09-30 $-0.04B $0.31B -13.56%
2022-06-30 $-0.05B $0.28B -17.88%
2022-03-31 $-0.21B $0.27B -78.52%
2021-12-31 $-0.19B $0.26B -90.65%
2021-09-30 $-0.17B $0.28B -117.29%
2021-06-30 $-0.15B $0.27B -190.29%
2021-03-31 $0.03B $0.03B 281.82%
2020-12-31 $0.03B $0.02B 652.63%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.533B $1.658B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00